The continuing spread of COVID-19 has the industry’s undivided attention, as clinical trial professionals seek the latest perspective on best practices during this unprecedented time. Clinical researchers with ongoing or upcoming clinical trials are working to understand, and ameliorate the impact of this pandemic on studies to keep them on track.

Join thousands of peers in these weekly online panels, designed to support healthcare researchers via the industry’s leading voices and perspectives. The panelists share expertise in real-time to inform our collective efforts to discover effective therapies, and minimize the disruption to ongoing and upcoming clinical trials.

REGISTER FOR 4/1 WEBINAR

ON-DEMAND

PART 1: Clinical Trials in the Era of COVID-19 – The Changes You Need to Make Now

Watch on-demand

In this webinar, our panel of experts discuss what you need to know about the impact of COVID-19 on your clinical trials:

  • Emergency changes to research, protocol amendments, and IRB review
  • Managing enrollment challenges and supporting your participants throughout the study
  • Ensuring the validity of your data as you shift to remote measurements
  • Minimizing the impact of missing data

Moderator:

Lindsay McNair, MD, MPH, MSB, Chief Medical Officer, WCG

Panelists:

Arthur L. Caplan, PhD, Professor of Bioethics and Founding Director, Division of Medical Ethics, NYU Langone Medical Center

David Borasky, MPH, CIP, Vice President, IRB Compliance, WCG

Suzanne Caruso, Vice President, Clinical Solutions, WCG

Mike Cioffi, Senior Vice President, Clinical Solutions and Strategic Partnerships, WCG MedAvante-ProPhase

ON-DEMAND

PART 2: Clinical Trials in the Era of COVID-19 – The Changes You Need to Make Now

Watch on-demand 

Date: March 25th
Time: 2:00 – 3:00 pm ET

In this webinar, our panel of experts discuss what you need to know about the impact of COVID-19 on your clinical trials:

  • How clinical sites and institutions are making decisions about what research should continue
  • What resources site teams are utilizing who are trying to shift study visits to virtual and remote assessments
  • What changes are being made to protocols based on site policies and precautions in response to COVID-19
  • The participant perspective- how we can manage fear, change, and messages about “non-essential” research priorities

Moderator:

Lindsay McNair, MD, MPH, MSB, Chief Medical Officer, WCG

Panelists:

Jonathan Zung, PhD, Executive Vice President

Mary Elizabeth Williams, Writer, Speaker, Patient Advocate

Lori Abrams, Senior Director, Advocacy

UPCOMING

PART 3: Clinical Trials in the Era of COVID-19 – The Changes You Need to Make Now

Click here to register. 

Date: April 1st
Time: 2:00 – 3:00 pm ET

In this webinar, our panel of experts continue to unpack what you need to know about the impact of COVID-19 on your clinical trials:

  • How to evaluate whether there is enough reliable data to draw meaningful clinical study conclusions
  • Assessing the status of each clinical study – what challenges, and opportunities, are presented based on study characteristics and timeline?
  • How can studies be designed now to build in future flexibility in schedules, procedures and analysis plans?
  • How can DMCs/DSMBs play a role in the assessment and modification of studies?
  • Safety data collection and reporting; Has anything changed?

Moderator:

Lindsay McNair, MD, MPH, MSB, Chief Medical Officer, WCG

Panelists:

Jonathan Seltzer, MD, MBA, MA, FACC, Chief Scientific Officer

Janet Wittes, PhD, Founder and President, WCG Statistics Collaborative